Fibrate use in the United States and Canada

JAMA. 2011 Jul 13;306(2):157; author reply 158-9. doi: 10.1001/jama.2011.945.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Drug Utilization
  • Dyslipidemias / complications
  • Dyslipidemias / drug therapy*
  • Fenofibrate / therapeutic use*
  • Fibric Acids / therapeutic use*
  • Humans
  • Practice Patterns, Physicians' / statistics & numerical data

Substances

  • Fibric Acids
  • Fenofibrate